PLN and diabetes mellitus: In conclusion, our study demonstrates that oral CB0313.1 administration (starting at weaning) in diabetes-prone NOD mice induces the accumulation of PLN and pancreatic Tregs, which is associated with a reduction in the islet infiltrates and islet-specific destructive autoimmunity, eventually preventing the onset and progression of diabetes (Figure 10).